Back

Discussion and Q&A

19 June 2026 (13:50 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular toxicity of fluoropyrimidines: Clinical challenges and emerging management strategies Cardiovascular Toxicity of Cancer Therapies Open Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Lyon (London, GB)
Presentation thumbnail
Cardiovascular toxicity of fluoropyrimidines
Doctor A. Lyon (London, GB)
Slides
Presentation thumbnail
Development of S-1 in metastatic colorectal cancer (mCRC)
Professor C. Punt (Utrecht, NL)
Slides
Presentation thumbnail
From science to clinical practice: treatment options following cardiovascular toxicity
Doctor I. Fabiani (Pisa, IT)
Slides

Access the full session

Session thumbnail
Cardiovascular toxicity of fluoropyrimidines: Clinical challenges and emerging management strategies
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 13:50 CET
You may be interested in
thumbnail
Congress Presentation
In between fjords and mountains; implementation of heart failure therapy in rural Norway - discussion
27 August 2023
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025
thumbnail
Congress Presentation
Roundtable discussion - Q&A
31 August 2025
thumbnail
Congress Presentation
Q&A and meeting close
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources